Becton Dickinson and Company (BDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Becton Dickinson and Company (BDX) has a cash flow conversion efficiency ratio of 0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($657.00 Million) by net assets ($25.28 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Becton Dickinson and Company - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Becton Dickinson and Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Becton Dickinson and Company for a breakdown of total debt and financial obligations.
Becton Dickinson and Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Becton Dickinson and Company ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Microchip Technology Inc
NASDAQ:MCHP
|
0.052x |
|
Danone SA
F:BSND
|
0.042x |
|
Coinbase Global Inc
NASDAQ:COIN
|
0.207x |
|
ITC Limited
NSE:ITC
|
0.086x |
|
Polski Koncern Naftowy ORLEN SA
WAR:PKN
|
0.055x |
|
Bank Central Asia Tbk
JK:BBCA
|
0.022x |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
0.116x |
|
American International Group Inc
NYSE:AIG
|
0.015x |
Annual Cash Flow Conversion Efficiency for Becton Dickinson and Company (1989–2025)
The table below shows the annual cash flow conversion efficiency of Becton Dickinson and Company from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BDX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $25.39 Billion | $3.43 Billion | 0.135x | -7.91% |
| 2024-09-30 | $25.89 Billion | $3.80 Billion | 0.147x | +26.61% |
| 2023-09-30 | $25.80 Billion | $2.99 Billion | 0.116x | +11.25% |
| 2022-09-30 | $25.28 Billion | $2.63 Billion | 0.104x | -46.94% |
| 2021-09-30 | $23.68 Billion | $4.65 Billion | 0.196x | +31.80% |
| 2020-09-30 | $23.77 Billion | $3.54 Billion | 0.149x | -5.38% |
| 2019-09-30 | $21.16 Billion | $3.33 Billion | 0.157x | +15.32% |
| 2018-09-30 | $20.99 Billion | $2.87 Billion | 0.136x | -30.71% |
| 2017-09-30 | $12.95 Billion | $2.55 Billion | 0.197x | -41.25% |
| 2016-09-30 | $7.63 Billion | $2.56 Billion | 0.335x | +45.54% |
| 2015-09-30 | $7.51 Billion | $1.73 Billion | 0.230x | -33.27% |
| 2014-09-30 | $5.05 Billion | $1.74 Billion | 0.345x | +15.47% |
| 2013-09-30 | $5.04 Billion | $1.51 Billion | 0.299x | -29.77% |
| 2012-09-30 | $4.14 Billion | $1.76 Billion | 0.426x | +19.75% |
| 2011-09-30 | $4.83 Billion | $1.72 Billion | 0.355x | +10.74% |
| 2010-09-30 | $5.43 Billion | $1.74 Billion | 0.321x | -3.86% |
| 2009-09-30 | $5.14 Billion | $1.72 Billion | 0.334x | -2.34% |
| 2008-09-30 | $4.94 Billion | $1.69 Billion | 0.342x | +20.20% |
| 2007-09-30 | $4.36 Billion | $1.24 Billion | 0.284x | +1.35% |
| 2006-09-30 | $3.84 Billion | $1.08 Billion | 0.281x | -26.24% |
| 2005-09-30 | $3.22 Billion | $1.23 Billion | 0.380x | +6.34% |
| 2004-09-30 | $3.07 Billion | $1.10 Billion | 0.358x | +14.43% |
| 2003-09-30 | $2.90 Billion | $905.70 Million | 0.313x | -6.96% |
| 2002-09-30 | $2.49 Billion | $836.03 Million | 0.336x | +0.50% |
| 2001-09-30 | $2.33 Billion | $778.64 Million | 0.334x | +6.26% |
| 2000-09-30 | $1.96 Billion | $615.49 Million | 0.315x | +28.89% |
| 1999-09-30 | $1.77 Billion | $431.80 Million | 0.244x | -21.33% |
| 1998-09-30 | $1.61 Billion | $500.80 Million | 0.310x | -2.89% |
| 1997-09-30 | $1.39 Billion | $442.70 Million | 0.320x | -8.02% |
| 1996-09-30 | $1.33 Billion | $460.40 Million | 0.347x | +2.89% |
| 1995-09-30 | $1.40 Billion | $472.20 Million | 0.338x | +4.34% |
| 1994-09-30 | $1.48 Billion | $479.50 Million | 0.324x | +47.43% |
| 1993-09-30 | $1.46 Billion | $319.80 Million | 0.220x | +13.59% |
| 1992-09-30 | $1.59 Billion | $308.20 Million | 0.193x | +3.72% |
| 1991-09-30 | $1.36 Billion | $254.10 Million | 0.186x | -11.26% |
| 1990-09-30 | $1.23 Billion | $259.00 Million | 0.210x | +53.14% |
| 1989-09-30 | $1.07 Billion | $146.90 Million | 0.137x | -- |
About Becton Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segme… Read more